VYNE Therapeutics (NASDAQ:VYNE) Stock, Earnings Estimates, EPS, And Revenue

VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-0.290
Quarterly Revenue
$121K
Annual Revenue
(as of Sep 30)
$493K

Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

VYNE Therapeutics (VYNE) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-0.29$-0.23-26.1 %
Jun 20242024-08-14$-0.22$-0.19-15.8 %
Mar 20242024-05-09$-0.15$-0.2437.5 %
Dec 20232024-02-29$-0.18$-0.5064.0 %

VYNE Therapeutics (VYNE) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-07$121.00K$110.00K10.0 %
Jun 20242024-08-14$198.00K$110.00K80.0 %
Mar 20242024-05-09$98.00K$100.00K-2.00 %
Dec 20232024-02-29$76.00K$150.00K-49.3 %

FAQ

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?

A

VYNE Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.29, which missed the estimate of $-0.23.

Q

What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?

A

VYNE Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch